These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34553215)

  • 21. Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination.
    Liu Y; Given KS; Harlow DE; Matschulat AM; Macklin WB; Bennett JL; Owens GP
    Acta Neuropathol Commun; 2017 Mar; 5(1):25. PubMed ID: 28340598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions.
    Gveric D; Kaltschmidt C; Cuzner ML; Newcombe J
    J Neuropathol Exp Neurol; 1998 Feb; 57(2):168-78. PubMed ID: 9600209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.
    Peterson JW; Bö L; Mörk S; Chang A; Trapp BD
    Ann Neurol; 2001 Sep; 50(3):389-400. PubMed ID: 11558796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical demyelination in PML and MS: Similarities and differences.
    Moll NM; Rietsch AM; Ransohoff AJ; Cossoy MB; Huang D; Eichler FS; Trapp BD; Ransohoff RM
    Neurology; 2008 Jan; 70(5):336-43. PubMed ID: 17914063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligodendrocytes and the early multiple sclerosis lesion.
    Prineas JW; Parratt JD
    Ann Neurol; 2012 Jul; 72(1):18-31. PubMed ID: 22829266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
    Kutzelnigg A; Lassmann H
    Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cuprizone model: regional heterogeneity of pathology.
    Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
    APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration.
    van Olst L; Rodriguez-Mogeda C; Picon C; Kiljan S; James RE; Kamermans A; van der Pol SMA; Knoop L; Michailidou I; Drost E; Franssen M; Schenk GJ; Geurts JJG; Amor S; Mazarakis ND; van Horssen J; de Vries HE; Reynolds R; Witte ME
    Acta Neuropathol; 2021 Jun; 141(6):881-899. PubMed ID: 33779783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
    Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination.
    Bajramović JJ; Plomp AC; Goes Av; Koevoets C; Newcombe J; Cuzner ML; van Noort JM
    J Immunol; 2000 Apr; 164(8):4359-66. PubMed ID: 10754336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
    Kira J
    Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.
    Trebst C; Sørensen TL; Kivisäkk P; Cathcart MK; Hesselgesser J; Horuk R; Sellebjerg F; Lassmann H; Ransohoff RM
    Am J Pathol; 2001 Nov; 159(5):1701-10. PubMed ID: 11696431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subpial demyelination in the cerebral cortex of multiple sclerosis patients.
    Bø L; Vedeler CA; Nyland HI; Trapp BD; Mørk SJ
    J Neuropathol Exp Neurol; 2003 Jul; 62(7):723-32. PubMed ID: 12901699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential role of iron in repair of inflammatory demyelinating lesions.
    Lee NJ; Ha SK; Sati P; Absinta M; Nair G; Luciano NJ; Leibovitch EC; Yen CC; Rouault TA; Silva AC; Jacobson S; Reich DS
    J Clin Invest; 2019 Oct; 129(10):4365-4376. PubMed ID: 31498148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
    Clarner T; Diederichs F; Berger K; Denecke B; Gan L; van der Valk P; Beyer C; Amor S; Kipp M
    Glia; 2012 Oct; 60(10):1468-80. PubMed ID: 22689449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions.
    Peterson JW; Bö L; Mörk S; Chang A; Ransohoff RM; Trapp BD
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):539-46. PubMed ID: 12071637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferating oligodendrocytes are present in both active and chronic inactive multiple sclerosis plaques.
    Solanky M; Maeda Y; Ming X; Husar W; Li W; Cook S; Dowling P
    J Neurosci Res; 2001 Aug; 65(4):308-17. PubMed ID: 11494366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis.
    Hendrickx DA; Koning N; Schuurman KG; van Strien ME; van Eden CG; Hamann J; Huitinga I
    J Neuropathol Exp Neurol; 2013 Feb; 72(2):106-18. PubMed ID: 23334594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel cell-based analysis reveals region-dependent changes in microglial dynamics in grey matter in a cuprizone model of demyelination.
    Roufagalas I; Avloniti M; Fortosi A; Xingi E; Thomaidou D; Probert L; Kyrargyri V
    Neurobiol Dis; 2021 Sep; 157():105449. PubMed ID: 34274460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.